source
- Understanding MET Alterations in Non‑Small Cell Lung Cancer and Emerging Targeted Treatment OptionsThe article outlines the primary MET alterations observed in non‑small cell lung cancer, focusing on gene amplification and exon 14 skipping mutations. It explains that these MET changes frequentl…
- TROP2 scoring and MTAP loss emerge as key biomarkers for NSCLC treatment decisionsResearchers are highlighting two molecular features-TROP2 expression and loss of the MTAP enzyme-as potential guides for therapy in non‑small cell lung cancer. Quantitative scoring of TROP2 by pat…